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Abstract 
Purpose: To report an unusual case of fulminant anterior uveitis, confirmed as 
endogenous Listeria monocytogenes infection.  
Subject: A 67-year-old man with multiple comorbidities acutely developed a severe 
endogenous anterior uveitis.  
Results: L. monocytogenes, a ubiquitous Gram-positive bacillus, was directly indicated by 
culture and PCR. Early and aggressive treatment with intravenous antibiotics likely 
prevented the endophthalmitis which most cases on record experienced. Our patient 
regained satisfactory visual acuity.  
Conclusions: Prompt antimicrobial therapy is paramount when severe endogenous 
uveitis develops in a patient with comorbidities, especially with systemic 
immunosuppression. Treatment solely with corticosteroids should be avoided. 
 
Introduction 
Listeria monocytogenes is a ubiquitous Gram-positive bacillus that rarely incites 
intraocular inflammation. Only 30 cases of uveitis due to L. monocytogenes have appeared 
in medical literature since 1967 [1]. The means of entry was hematogenous in each 
instance. 
Cephalosporins are generally ineffective as treatment, but a wide range of antibiotics 
can be used. Based on expected synergy, a combination of aminopenicillin (amoxicillin or 
ampicillin) and aminoglycoside is the current treatment of choice [2].  
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Case Report 
A 67-year-old Turkish man presented with deteriorating vision (to hand motion) and pain that 
increasingly developed in the right eye over a period of 9 days. He was using gentamicin ointment 3 
times daily (t.i.d.) for the right eye for 2 days. He had been hospitalized for 17 days with dyspnea, 
brought on by chronic obstructive pulmonary disease (COPD) and chronic heart failure. This patient 
also suffered from renal insufficiency and hypertension and had previously undergone aortic valve 
replacement. Esophagogastroduodenoscopy revealed a Mallory-Weiss syndrome and antral gastritis. 
Recently, the long-term oral prednisolone therapy he received daily had been increased from 12.5 to 75 
mg because the COPD was getting worse. His ophthalmologic medical history was noncontributory and 
the left eye was unremarkable. No extraocular septic focus was identifiable. 
In the right eye, the conjunctiva was hyperemic, the anterior chamber was visibly inflamed with a 
2-mm hypopyon, grayish keratic precipitates, a fixed pupil, and abundant fibrin in front of the lens. 
Although the posterior segment was not visible, no vitreous involvement was evident in 10 MHz B-Scan 
ultrasound. Intraocular pressure of the right eye was 35 mm Hg. 
Our tentative diagnosis was a bacterial endogenous endophthalmitis with other forms of anterior 
uveitis as the differential diagnoses. We replaced the existing topical therapy of gentamicin ointment 
with hourly ofloxacin eye drops, plus night time atropine ointment, and began intravenous delivery of 
ceftazidime (2 g t.i.d.), tobramycin (40 mg/40 mg/80 mg), and clindamycin (600 mg t.i.d.) in divided 
daily doses. On day 2, the ofloxacin eye drops were cut to 5 times daily, and we added prednisolone eye 
drops t.i.d. By day 3, epithelial edema and a 2.5-mm hypopyon were noted. Aqueous humor was then 
collected by paralimbal paracentesis for microbial study. The hypopyon subsequently dissolved and the 
intraocular pressure normalised by day 4. 
After 23 days, L. monocytogenes was identified from the aqueous humor sample. Cultures proved 
positive for Gram-positive rods, confirmed as L. monocytogenes by gene sequencing (16S rRNA). The 
patient’s eye had clearly improved, however, in advance of the diagnosis, so therapy remained 
unchanged. Four weeks after his referral, both anterior and posterior segment examinations showed no 
sign of inflammation, except some pigmentary transfer from iris to lens. Given bilateral cataracta 
provecta, his visual acuity was 0.4 on the right and 0.5 on the left eye. 
Discussion 
Patients with multiple comorbidities are often vulnerable to uncommon infections of 
the eye from ubiquitous, opportunistic bacteria. L. monocytogenes, in particular, may be 
acquired by humans through direct contact with infected animals, contaminated food 
(especially raw milk, cheese, ice cream), and unprocessed products of tainted raw meat 
and fish. In fact, this organism is one of the most frequently transmitted pathogens in 
food [3]. For bodily dissemination and seeding of sites such as the eye, phagocytosis by 
phagocytes and hematogenous transport are essential. Intracellular sequestration protects 
this species from exposure to antibodies and other host defences, thus explaining why all 
case reports of L. monocytogenes uveitis to date have been endogenous. Onset of 
gastrointestinal symptoms requires at least 12 hours, while the incubation period for areas 
elsewhere is several days to weeks. 
Previous reports indicate that anterior uveitis of L. monocytogenes may be complicated 
by secondary glaucoma, fibrinous exudate leading to posterior synechiae, and pigmentary 
precipitates involving the endothelium and anterior lens capsule. Some studies have 
documented a brown or blackish hypopyon [4], whereas a more characteristic white 
colour was noted in our case. 
Gene sequencing (16S rRNA) facilitates a timely diagnosis [5], but paucity of viable 
organisms in the culture specimen could easily account for delayed laboratory results.  
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This type of uveitis is also typically worsened by standard cortisone therapy, so it is 
fortunate that we used high-dose intravenous antibiotics from the start. The 
cephalosporin, ceftazidime, does not penetrate lysosomes and likely had little or no 
impact [2]. Clindamycin, as our second agent, is a lincosamide antibiotic capable of 
lysosomal access and is generally effective against this organism [2]. The third antibiotic 
selected, tobramycin, is an aminoglycoside that is bactericidal with L. monocytogenes and 
is the first choice, in combination with an aminopenicillin, to treat such infections [2]. 
Because of early, aggressive antibiotic use, our patient recovered uneventfully and did not 
develop the endophthalmitis that routinely plagued similar cases depicted in the 
literature. Various authors share the opinion that early treatment confers the best 
prognosis with respect to preserving visual acuity [6]. 
Conclusion 
The above clinical events emphasize the need to consider a bacterial source and 
promptly initiate antibiotic treatment, whenever a patient of considerable medical 
complexity, especially with systemic immunosuppression (e.g. oral therapy with 
corticosteroids), develops endogenous anterior uveitis. Corticosteroids as the sole choice 
of therapy should be avoided. 
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